Muneer Satter's first interest in medicine wasn't rooted in genomics. It was in seeing the health care needs of his loved ones and of the world's most vulnerable. In his professional life, before making investments in biotech, he sought out the opinions of expert doctors at Mayo Clinic.

"The more I talked to doctors, the more I started gravitating there," the Chicago investor says. "That's when I realized biotech was going to be a big deal."

The Satter Foundation is a Principal Benefactor to Mayo Clinic's mission, supporting the Center for Individualized Medicine's efforts to discover, translate and apply genomic medicine services and products to each patient.

Continue reading at Mayo Clinic's Medical Science Blog.